Replay available

Guardant Health, Inc. (GH) Q2 2026 Earnings Call

Guardant Health, Inc. (NASDAQ: GH) Q2 2026 earnings conference call, held 2026-07-30. Replay captured from the company's public earnings webcast.

Thu, July 30, 2026 at 4:30 PMendedReplay
Guardant Health, Inc. (GH) Q2 2026 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Subu Nambi

Analyst, Guggenheim

Dan Leonard

Analyst, RBC Capital Markets

Puneet Souda

Analyst, Lear Inc.

Kyle Mixon

Analyst, Canaccord Genuity

Mark Massaro

Analyst, BTIG

AmirAli Talasaz

Co-CEO

Helmy Eltoukhy

Co-CEO

Mike Bell

Chief Financial Officer

Dan Brennan

Analyst, TD Cowen

Evie Koslowski

Analyst, Goldman Sachs

Brad Bowers

Analyst, Mizuho

Daniel Markowitz

Analyst, Evercore

Catherine Schult

Analyst, Baird

Paige Chamberlain

Analyst, Wolfe Research

Casey Woodring

Analyst, JPMorgan

Zarak Khurshid

VP, Investor Relations

Callum Titchmarsh

Analyst, Morgan Stanley

Replay transcript excerpt

Hello everyone, thank you for joining us and welcome to the Gardent Health second quarter 2026 earnings call. After today's prepared remarks, we will host a question and answer session. If you would like to ask a question, please press star 1 to raise your hand. To withdraw your question, please press star 1 again. I will now hand the conference over to Zarak Khurshid, VP of Investor Relations. Zarak, please go ahead. Thank you. Earlier today, Garden Health released financial results for the quarter ended June 30th, 2026. Joining me today from Garden are co-CEOs Helmy Eltoukhy and AmirAli Talasaz and Chief Financial Officer Mike Bell. Before we begin, I'd like to remind you that during this call, we will be making forward-looking statements within the meaning of federal securities laws. These statements involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated. This call will also include a discussion of non-GAAP financial measures, which are adjusted to exclude certain specified items, additional information regarding material risks and uncertainties, as well as the non-GAAP financial reconciliation to most directly comparable GAAP financial measures are available in the press release GARDEN issued today, as well as in our 10Q and other filings with the SEC. GARDEN disclaims any intention or obligation to update or revise financial projections and forward-looking statements, whether because of new information, future events, or otherwise, except as required by law. The information in this conference call is accurate only as is the live broadcast. With that, I would like to turn the call over to Helmy. Thanks, Eric. Good afternoon, and thank you for joining our second quarter 2026 earnings call. Sta...

More from Guardant Health, Inc.